Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-07 Purchase | 2022-06-07 5:30 pm | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 25,000 | $1.3305 | $33,263 | 29,233 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Option Award | 2024-12-04 9:11 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 127,500 | $0 | 127,500 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 4:00 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 1,387 | $1.683 | 3,117 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:24 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 112,500 | $0 | 112,500 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:02 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-16 5:26 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,524 | $0.4973 | 43,271 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 08:01 am | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,863 | $0.459 | 38,747 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:02 pm | N/A 2033-01-16 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-11-15 Option Award | 2022-11-16 6:30 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,651 | $0.4684 | 33,884 (Direct) | View |
| 2022-06-20 Option Award | 2022-06-22 4:17 pm | N/A 2032-06-19 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 235,541 | $0 | 235,541 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 8:46 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,233 | $1.53 | 4,233 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 8:11 pm | N/A 2032-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 235,541 | $0 | 235,541 (Direct) | View |
| 2021-08-25 Option Award | 2021-08-27 6:01 pm | N/A 2030-12-09 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 387,787 | $0 | 387,787 (Direct) | View |